PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 39.91
-1.16 (-2.82%)
At close: Apr 21, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 5.49 billion as of April 21, 2026. Its market cap has increased by 25.42% in one year.
Market Cap
5.49B
Enterprise Value
5.36B
Revenue
667.47M
Ranking
n/a
PE Ratio
156.02
Stock Price
39.91
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 5.49B, an increase of 39.38%. That is a compound annual growth rate of 10.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 5.49B | 33.61% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 6.31B |
| Kexing Biopharm | 6.27B |
| Shenzhen Weiguang Biological Products | 6.21B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.14B |
| Beijing Konruns Pharmaceutical | 6.14B |
| Novogene | 5.87B |
| Innovita Biological Technology | 5.85B |
| Wuhan Hvsen Biotechnology | 5.68B |